Status:
NOT_YET_RECRUITING
Treatment of CDI and Recurrence With Fecal Microbiota Transplant Using Promicrobioma
Lead Sponsor:
Hospital Universitario Evangelico de Curitiba
Conditions:
Clostridium Difficile Infections
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The increasing inappropriate use of antimicrobials, in addition to increasing selective pressure and inducing environmental resistance, is also a risk factor for the development of Clostridioides diff...
Detailed Description
INTRODUCTION The increasing inappropriate use of antimicrobials, in addition to increasing selective pressure and inducing environmental resistance, is also a risk factor for the development of Clost...
Eligibility Criteria
Inclusion
- The inclusion criteria are:
- Over 18 years old;
- Hospitalized patients;
- Clinical and laboratory diagnosis of CDI;
- Signing the informed consent form
- For primary CDI, use of antibiotics for less than 72 hours; and for recurrent CDI, previous confirmed CDI with clinical response to antibiotic treatment and CDI recurrence within 8 weeks.
- The exclusion criteria are:
- Pregnant patients
- Severe form of CDI requiring surgery
- Impossibility of performing the colonoscopy procedure or using a nasoenteral tube
Exclusion
Key Trial Info
Start Date :
May 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2026
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT06107569
Start Date
May 1 2024
End Date
January 1 2026
Last Update
February 29 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.